Emend Powder For Solution For Injection 188Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Emend: Powder for solution for injection (188mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FOSAPREPITANT (fos ap RE pi tant) is used together with other medicines to prevent nausea and vomiting caused by cancer treatment (chemotherapy).

In-Depth Information

Emend 115mg Powder for Injection

NDC: 000063884
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Chemotherapy-induced Nausea/vomiting Prophylaxis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Emend 115mg Powder for Injection

Reported Side Effects for Emend 115mg Powder for Injection

Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Sneezing Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hole In Intestines Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<7.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elated Mood Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Tiredness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Miosis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Photosensitivity Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Abnormal Dreams Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Intestine Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
<6.0%*
Severity: MODERATE
Onset: RAPID
Low Potassium Levels Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Diaphoresis Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
0.5-6.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
0.5-3.0%*
Severity: MODERATE
Onset: DELAYED
Belching Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Cough Incidence:
0.5-5.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
>0.5%*
Severity: MILD
Onset: RAPID
Heartburn Incidence:
0.5-4.0%*
Severity: MILD
Onset: DELAYED
Bruise Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Hypoxia Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Yeast Infection Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
>0.5%*
Severity: SEVERE
Onset: RAPID
Muscle And/Or Bone Pain Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
0.5-5.0%*
Severity: MILD
Onset: DELAYED
Low Blood Sodium Levels Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
0.5-5.0%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Low Blood Volume Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Weight Loss Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Hot Flashes Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Hives Incidence:
>0.5%*
Severity: MILD
Onset: RAPID
Dry Mouth Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.5-6.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Protein In The Urine Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Low Albumin In Blood Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
0.5-7.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
>0.5%*
Severity: MODERATE
Onset: EARLY
Wound Dehiscence Incidence:
>0.5%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
>0.5%*
Severity: MILD
Onset: EARLY
Decreased Breathing Incidence:
>0.5%*
Severity: MODERATE
Onset: RAPID
Low White Blood Cells Incidence:
0.5-13.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
>0.5%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Low Body Temperature Incidence:
>0.5%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
1.5-7.6%*
Severity: MILD
Onset: RAPID
Constipation Incidence:
2.2-9.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
2.2-9.0%*
Severity: MILD
Onset: EARLY
Hiccups Incidence:
4.0-5.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
4.2%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Emend 115mg Powder for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Emend 115mg Powder for Injection(Fosaprepitant dimeglumine)
Grapefruit juice and Aprepitant, Fosaprepitant(Fosaprepitant dimeglumine)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Aprepitant, Fosaprepitant. Do not significantly increase grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible.
Moderate Lifestyle Interaction
Marijuana and Emend 115mg Powder for Injection(Fosaprepitant dimeglumine)
Marijuana and Aprepitant, Fosaprepitant(Fosaprepitant dimeglumine)
Aprepitant, Fosaprepitant can theoretically alter the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may get worse if you take Aprepitant, Fosaprepitant. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Emend

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.